This study examined the evolution of volatile and non-volatile compounds of a Cypriot monovarietal cultivar Maratheftiko red wine over a span of six years (2019–2024). Several physicochemical properties of the wines were evaluated. Alcohol content and volatile acidity remained stable; acidity and malic acid are the main differentiating factors among vintages. In addition, bioactive molecules in the wines showed a distinct vintage effect, with the 2024 vintage exhibiting significantly higher concentrations. For instance, the high concentration of polyphenols (3877.86 mg gallic acid equivalents per L), tannins (688.43 mg of catechin equivalents per L), flavonoids (506.90 mg of rutin equivalents per L), and anthocyanins (413.74 mg of cyanidin equivalents per L) contributed to the high antioxidant capacity of the specific vintage, as FRAP and DPPH assays were measured at 44.60 and 29.91 mmol of ascorbic acid equivalents per L, respectively. Furthermore, the intense crimson color of this red wine could be attributed to the high concentration of the abundant anthocyanin malvidin-3-O-glucoside in this vintage (21.62 mg/L). On the other hand, it was observed that the latest vintage showed high polyphenol concentration but low volatile compound concentration. This pattern was ascertained through correlation analyses and could be attributed to an unsatisfactory level of the aging process. Correlation analysis (Pearson’s r) confirmed inverse relationships between polyphenol concentration and volatile compounds (r = −0.62, p < 0.05). Principal component analysis (PCA) further highlighted the 2024 as an outlier vintage, distinguished by elevated phenolic and antioxidant profiles.
Toulaki et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: